| Financial Year |
March 31 2023 |
| Monetary Funds |
423,955,485.77 |
| Held-for-trading Financial Assets |
453,500,000.00 |
| Notes Receivable |
90,657,915.34 |
| Accounts Receivable |
970,824,895.42 |
| Advances to Suppliers |
55,111,080.02 |
| Other Receivables |
42,301,747.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
854,184,297.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
100,000,000.00 |
| Other Current Assets |
4,665,500.07 |
| Total Current Assets |
3,107,486,861.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
203,917,464.76 |
| Investment Properties |
7,445,390.65 |
| Fixed Assetes |
428,209,991.88 |
| Under-construction Projects |
100,926,771.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
202,324,441.95 |
| R&D expenses |
596,293.23 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,818,608.16 |
| Deferred Income Tax Assets |
81,671,854.85 |
| Other Non-Current Assets |
167,488,486.36 |
| Sub-Total of Non-Current Assets |
1,258,650,217.39 |
| Total Assets |
4,366,137,079.08 |
| Short-Term Loans |
310,359,498.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
152,000,000.00 |
| Accounts Payable |
545,105,256.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,517,288.16 |
| Taxes Payable |
20,355,432.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
50,273,854.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
37,046,291.90 |
| Sub-Total of Current Liabilities |
1,397,634,944.29 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,641,616.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,701,616.42 |
| Total Liabilities |
1,402,336,560.71 |
| Paid-In Capital(Or Share Stock) |
1,782,793,836.00 |
| Capital Surplus |
379,683,511.72 |
| Surplus Reserve |
58,409,087.81 |
| LESS:Treasury Stock |
21,799,995.64 |
| Undistributed Profits |
709,730,600.06 |
| Minority Stockholder's Interest |
45,878,880.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,917,921,638.23 |
| Owner's Equity（Stockholder's Equity） |
2,963,800,518.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,366,137,079.08 |
